A Phase II Study of VELCADE (Bortezomib) in Combination With Bendamustine and Rituximab in Subjects With Relapsed or Refractory Follicular Lymphoma
Clinical trial NCT00636792 · COMPLETED
Trial details
- NCT number
- NCT00636792
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-01
- Primary completion
- 2010-05-01
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.